Home Aminos N-(3-acetyl-4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)butanamide hydrochloride

N-(3-acetyl-4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)butanamide hydrochloride

CAS No.:
34381-68-5
Catalog Number:
AG007FXT
Molecular Formula:
C18H29ClN2O4
Molecular Weight:
372.8869
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$57
- +
5g
98%
In Stock USA
United States
$175
- +
25g
98%
In Stock USA
United States
$700
- +
Product Description
Catalog Number:
AG007FXT
Chemical Name:
N-(3-acetyl-4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)butanamide hydrochloride
CAS Number:
34381-68-5
Molecular Formula:
C18H29ClN2O4
Molecular Weight:
372.8869
MDL Number:
MFCD00078860
IUPAC Name:
N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide;hydrochloride
InChI:
InChI=1S/C18H28N2O4.ClH/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3;/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23);1H
InChI Key:
KTUFKADDDORSSI-UHFFFAOYSA-N
SMILES:
CCCC(=O)Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O.Cl
EC Number:
251-980-3
NSC Number:
757412
Properties
Complexity:
401  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
372.182g/mol
Formal Charge:
0
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
372.89g/mol
Monoisotopic Mass:
372.182g/mol
Rotatable Bond Count:
10  
Topological Polar Surface Area:
87.7A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Active components of frequently used β-blockers from the aspect of computational study. Journal of molecular modeling 20120901
A trans-specific polymorphism in ZC3HAV1 is maintained by long-standing balancing selection and may confer susceptibility to multiple sclerosis. Molecular biology and evolution 20120601
Follow-up with exercise test of effort-induced ventricular arrhythmias linked to ryanodine receptor type 2 gene mutations. The American journal of cardiology 20120401
Infantile haemangioma and β-blockers in otolaryngology. European annals of otorhinolaryngology, head and neck diseases 20111101
Recombination patterns in dicot-infecting mastreviruses mirror those found in monocot-infecting mastreviruses. Archives of virology 20110801
Applicability of Greulich and Pyle method for age assessment in forensic practice on an Italian sample. International journal of legal medicine 20110501
1H and 13C NMR characteristics of β-blockers. Magnetic resonance in chemistry : MRC 20110501
Mechanisms of fibrinogen-acebutolol interactions: Insights from DSC, CD and LS. Colloids and surfaces. B, Biointerfaces 20110201
Mammalian selenocysteine lyase is involved in selenoprotein biosynthesis. Journal of nutritional science and vitaminology 20110101
Potential for biodegradation and sorption of acetaminophen, caffeine, propranolol and acebutolol in lab-scale aqueous environments. Journal of hazardous materials 20101115
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Management of infantile subglottic hemangioma: acebutolol or propranolol? International journal of pediatric otorhinolaryngology 20100801
Beta-blocking agent for treatment of infantile hemangioma. Plastic and reconstructive surgery 20090601
First record of Prorocentrum lima (Dinophyceae) inside harbor areas and along the Abruzzo region coast, W Adriatic. Marine pollution bulletin 20090401
Using supported liquid extraction together with cellobiohydrolase chiral stationary phases-based liquid chromatography with tandem mass spectrometry for enantioselective determination of acebutolol and its active metabolite diacetolol in spiked human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090115
Determination of selected beta-receptor antagonists in biological samples by solid-phase extraction with cholesterolic phase and LC/MS. Analytical and bioanalytical chemistry 20090101
Simultaneous determination of beta-blockers in human plasma using liquid chromatography-tandem mass spectrometry. Biomedical chromatography : BMC 20080701
Stability of chosen beta-adrenolytic drugs of different polarity in basic environment. Journal of AOAC International 20080101
A population-based analysis of the class effect of beta-blockers after myocardial infarction. American heart journal 20070201
Evaluation of chromatographic descriptors for the prediction of gastro-intestinal absorption of drugs. Journal of chromatography. A 20070105
Spectrophotometric and spectrofluorimetric methods for analysis of acyclovir and acebutolol hydrochloride. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070101
Evaluation of the impact on entomocoenosis of active agents allowed in organic olive farming against Bactrocera oleae (Gmelin, 1790). Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes 20070101
[Interrelationship between changes of rate and variability of cardiac rhythm under influence of beta-adrenoblockers]. Kardiologiia 20070101
Spectrophotometric and spectrofluorimetric methods for analysis of tramadol, acebutolol and dothiepin in pharmaceutical preparations. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20061201
Spectrophotometric and spectrofluorimetric methods for analysis of acyclovir and acebutolol hydrochloride. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20061101
Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. The Journal of pediatrics 20060901
Arrhythmogenic right ventricular dysplasia in pregnancy: a case report. The Journal of reproductive medicine 20060901
Spectrofluorimetric determination of drugs containing active methylene group using N1-methyl nicotinamide chloride as a fluorigenic agent. Chemical & pharmaceutical bulletin 20060701
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Transport of acebutolol through rabbit corneal epithelium. Biological & pharmaceutical bulletin 20060401
Stability of atenolol, acebutolol and propranolol in acidic environment depending on its diversified polarity. Pharmaceutical development and technology 20060101
Effects of grapefruit juice on the pharmacokinetics of acebutolol. British journal of clinical pharmacology 20051201
[Antihypertensive therapy with left cardiac insufficiency]. Medizinische Monatsschrift fur Pharmazeuten 20051201
Assay of acebutolol in pharmaceuticals by analytical capillary isotachophoresis. Journal of chromatography. A 20050715
Acebutolol-induced subacute cutaneous lupus erythematosus. Skin pharmacology and physiology 20050101
[Cholinergic urticaria revealed by beta-blockers: case report and therapeutic management]. Therapie 20050101
Medication error caused by confusing drug blisters. Lancet (London, England) 20040626
Nodal and BMP2/4 signaling organizes the oral-aboral axis of the sea urchin embryo. Developmental cell 20040301
Sleep-deprived mice show altered cytokine production manifest by perturbations in serum IL-1ra, TNFa, and IL-6 levels. Brain, behavior, and immunity 20031201
Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects. Medical science monitor : international medical journal of experimental and clinical research 20030801
Pharmacokinetic changes of acebutolol after oral administration in rabbits with diabetes mellitus induced by alloxan. Archives of pharmacal research 20030601
Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: the effect of gastric pH on double-peak phenomena. International journal of pharmaceutics 20030414
Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome. Journal of medical genetics 20030101
[Acute poisoning with nifedipine and acebutol: two cases]. Przeglad lekarski 20030101
[Toxicologic analysis of some adrenergic-beta blockers in the diagnosis of intoxications]. Archiwum medycyny sadowej i kryminologii 20030101
Electrocardiographic changes associated with beta-blocker toxicity. Annals of emergency medicine 20021201
The effect of selective beta1-blockade on EMG signal characteristics during progressive endurance exercise. European journal of applied physiology 20021201
Beta-adrenergic-receptor blockade and myocardial ischemia: something old, something new. Journal of cardiothoracic and vascular anesthesia 20021201
Beta-adrenergic blockade during severe ischemia. Journal of cardiothoracic and vascular anesthesia 20021201
Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure. Archives of pharmacal research 20020801
Isolation and properties of genetically defined strains of the methylotrophic yeast Hansenula polymorpha CBS4732. Archives of microbiology 20020201
Mutations of muscle glycogen synthase that disable activation by glucose 6-phosphate. Archives of biochemistry and biophysics 20020115
Cardioselective beta-blockers for reversible airway disease. The Cochrane database of systematic reviews 20020101
[Acebutolol in the treatment of arterial hypertension in pregnancy--comparison with commonly used hypertensive agents]. Ceska gynekologie 20020101
Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis. Microbiology (Reading, England) 20011201
beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome. Journal of medical genetics 20010901
Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure. European journal of heart failure 20010601
Effect of an alpha-blocker (Nicergoline) and of a beta-blocker (Acebutolol) on the in vitro biosynthesis of vascular extracellular matrix. Pathologie-biologie 20010501
First derivative spectrophotometric, TLC-densitometric, and HPLC determination of acebutolol HCL in presence of its acid-induced degradation product. Journal of pharmaceutical and biomedical analysis 20010201
Cardioselective beta-blocker use in patients with reversible airway disease. The Cochrane database of systematic reviews 20010101
[Interaction between melilot and acenocoumarol? (Melilotruscus aculeatus)]. Therapie 20010101
Comparison of the effect of perindopril and acebutolol on cerebral hemodynamics in hypertensive patients. Cardiovascular drugs and therapy 20010101
[The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment]. Przeglad lekarski 20010101
Acebutolol-induced ventricular tachycardia reversed with sodium bicarbonate. Journal of toxicology. Clinical toxicology 19990101
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension (Dallas, Tex. : 1979) 19970101
Fulminant myasthenia gravis soon after initiation of acebutolol therapy. European neurology 19900101
[Monotherapy with acebutolol in hypertensive diabetic patients]. Polski tygodnik lekarski (Warsaw, Poland : 1960) 19900101
Effect of intravenous and oral acebutolol in patients with bundle branch block. International journal of cardiology 19860201
Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients. European journal of clinical pharmacology 19860101
Central action of beta-adrenoceptor antagonists on blood pressure after acute administration in rats. Journal de pharmacologie 19860101
Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol. American heart journal 19850501
Comparison of acebutolol and hydrochlorothiazide in essential hypertension. American heart journal 19850501
The psychological side effects of acebutolol and atenolol. British journal of clinical pharmacology 19840301
[Antidotal treatment of acebutolol poisoning]. Arzneimittel-Forschung 19840101
Pharmacological properties of diacetolol (M & B 16,942), a major metabolite of acebutolol. European journal of pharmacology 19820507
[Dose-response relationship and duration of action of acebutolol / investigations on heart rate behaviour and ischemic ST-segment depression]. Arzneimittel-Forschung 19820101
Addition of acebutolol to diuretics in hypertension. Clinical pharmacology and therapeutics 19811201
New drugs for treating cardiac arrhythmias. Postgraduate medicine 19810101
Effects of beta-adrenergic blocking drugs in hypertensive rats. Journal of pharmacobio-dynamics 19800101
[Electrophysiological properties of injectable acebutolol. A study of one case of auriculo-ventricular block observed under acebutolol per os (author's transl)]. Annales de cardiologie et d'angeiologie 19790101
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension. British medical journal 19780805
Cutaneous vasculitis due to acebutolol. Lancet (London, England) 19770827
Suppression of premature ventricular contractions by acebutolol. Circulation 19770501
[Test with trinitrine. Clinical evaluation of the beta anti-adrenergic effect of acebutolol in arterial hypertension]. La Nouvelle presse medicale 19751231
[Pharmacology of acebutolol in animals]. La Nouvelle presse medicale 19751231
Properties